These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 2192175

  • 1. [Clinical significance of gamma-seminoprotein assay as a tumor marker].
    Eto K, Ueda S.
    Nihon Rinsho; 1990 Feb; 48 Suppl():920-4. PubMed ID: 2192175
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
    Ishihara Y, Hiromoto Y, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
    [Abstract] [Full Text] [Related]

  • 3. [Clinical studies of gamma-seminoprotein in prostatic disease. I. Clinical evaluation of serum gamma-seminoprotein].
    Hasegawa S, Nakashima J, Nakashima Y, Nakamura S, Kimura S.
    Hinyokika Kiyo; 1987 Dec; 33(12):2055-8. PubMed ID: 3329453
    [Abstract] [Full Text] [Related]

  • 4. Re: Gamma-seminoprotein--a new tumor marker in prostatic cancer?
    Maier U.
    Br J Urol; 1991 Dec; 68(6):664. PubMed ID: 1773308
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
    Yoshiki T, Okada K, Oishi K, Yoshida O.
    Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers].
    Yamaguchi K, Tanaka M, Kitagawa N, Kotake T, Yanagi S, Ito H.
    Hinyokika Kiyo; 1989 Jun; 35(6):987-91. PubMed ID: 2478006
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between reactivation and tumor markers in prostatic cancer].
    Fuse H, Umeda K, Kazama T, Sakamoto M, Sakai T, Fujishiro Y, Mizuno I, Katayama T.
    Hinyokika Kiyo; 1991 Jan; 37(1):39-43. PubMed ID: 1707217
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [Abstract] [Full Text] [Related]

  • 10. [Clinical studies of gamma-seminoprotein in prostatic disease. II. Immunohistochemical study of gamma-seminoprotein].
    Nakashima J, Hasegawa S, Nakashima Y, Nakamura S, Kimura S, Tachibana M, Deguchi N, Tazaki H.
    Hinyokika Kiyo; 1987 Dec; 33(12):2059-63. PubMed ID: 3329454
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical study of tumor markers in prostatic carcinoma--an investigation on the simultaneous measurement of prostatic acid phosphatase (PAP), prostatic antigen (PA) and gamma-seminoprotein (gamma-Sm)].
    Tsukamoto T, Kumamoto Y, Yamazaki K, Umehara T, Miyao N, Ohmura K, Iwazawa M.
    Hinyokika Kiyo; 1988 Jun; 34(6):987-95. PubMed ID: 2464917
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S, Akakura K, Masai M, Isaka S, Shimazaki J.
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ultrastructural localizations of beta-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: comparison with gamma-seminoprotein, another prostate-specific antigen.
    Ito Y, Tsuda R, Kimura H.
    J Lab Clin Med; 1989 Sep; 114(3):272-7. PubMed ID: 2475560
    [Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of a prostate-specific antigen as a serum marker of prostatic cancer].
    Park YC, Kiwamoto H, Nishioka T, Tsujihashi H, Mitsubayashi S, Matsuura T, Akiyama T, Kurita T, Miyamoto T.
    Hinyokika Kiyo; 1987 Jun; 33(6):883-8. PubMed ID: 2445188
    [Abstract] [Full Text] [Related]

  • 19. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
    Akimoto S, Akakura K, Shimazaki J.
    Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
    [Abstract] [Full Text] [Related]

  • 20. Two prostate-specific antigens, gamma-seminoprotein and beta-microseminoprotein.
    Hara M, Kimura H.
    J Lab Clin Med; 1989 May; 113(5):541-8. PubMed ID: 2654306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.